Unlike 21-hydroxylase deficiency, molecular-genetic studies of 11β-OHD are relatively fewer, and a number of identified CYP11B1 mutations have not been functionally characterized [5, 13]. The gene discussed is CYP11B1; the disease is classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency.